MCD
52
-5
XOM
42
-6
TDC
67
-4
DE
42
3
DAL
84
-3
VRSN
53
-5
WDC
37
-3
FFIV
66
-4
FRT
41
-2
STZ
52
-6
EL
15
-3
SIG
44
-3
CPB
22
-5
SRE
63
2
TEL
60
-8
WBA
43
-4
HAL
48
-3
BMY
55
-8
C
62
4
ADBE
47
-9
MCD
52
-5
XOM
42
-6
TDC
67
-4
DE
42
3
DAL
84
-3
VRSN
53
-5
WDC
37
-3
FFIV
66
-4
FRT
41
-2
STZ
52
-6
EL
15
-3
SIG
44
-3
CPB
22
-5
SRE
63
2
TEL
60
-8
WBA
43
-4
HAL
48
-3
BMY
55
-8
C
62
4
ADBE
47
-9
Financhill
Back

Atara Biotherapeutics Stock Predictions

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.
Sell
48

ATRA
Atara Biotherapeutics

Last Price:
11.99
Seasonality Move:
37.22%

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Atara Biotherapeutics Stock Forecast

  • Over the next 52 weeks, Atara Biotherapeutics has on average historically risen by 3% based on the past 10 years of stock performance.
  • Atara Biotherapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Atara Biotherapeutics Stock Undervalued?
    The current Atara Biotherapeutics [ATRA] share price is $12.00. The Score for ATRA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ATRA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Atara Biotherapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Atara Biotherapeutics has on average historically risen by 3% based on the past 10 years of stock performance.

Atara Biotherapeutics Stock Rating

Sell
48
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics overpriced?

  • Atara Biotherapeutics has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Atara Biotherapeutics Stock Price History

Is ATRA stock going to rise?

  • The current trend is moderately bullish and ATRA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atarabio.com

52-Week Data

52-Week High:
39.50
52-Week Low:
6.50

Prediction Charts

Market Cap:
68.09M
Price in USD:
12.00
Volume:
107.87K
Beta:
0.95

Technical Analysis

SMA50:
9.00
SMA100:
8.84
SMA200:
12.83
52-Wk Change:
26.25%

Stock Predictions

  • Is Atara Biotherapeutics stock public?
    Yes, Atara Biotherapeutics is a publicly traded company.
  • What is the Atara Biotherapeutics stock quote today?
    The Atara Biotherapeutics stock price is 12.00 USD today.
  • How to buy Atara Biotherapeutics stock online?
    You can buy Atara Biotherapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 8.82 8.87 9.19 8.61
Oct-30 8.87 9.58 9.85 8.87
Oct-31 9.46 8.93 9.70 8.90
Nov-1 9.10 9.71 9.82 8.80
Nov-4 9.71 11.63 11.85 9.65
Nov-5 11.77 10.28 11.87 9.95
Nov-6 10.71 10.01 10.71 9.21
Nov-7 10.04 10.10 10.44 9.89
Nov-8 10.10 11.31 11.48 10.02
Nov-11 11.61 11.77 12.46 11.33
Nov-12 11.55 11.67 12.07 11.10
Nov-13 12.00 14.38 14.93 11.91
Nov-14 14.48 12.77 14.83 12.63
Nov-15 12.91 12.00 12.91 11.50

Atara Biotherapeutics Earnings

Atara Biotherapeutics Earnings Report: Per Share Atara Biotherapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Atara Biotherapeutics Forecast Revenue Growth

Atara Biotherapeutics Stock Analysis: Historical quarterly revenues per share for Atara Biotherapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $13.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $56.86 per share, and a decrease next year of $3.35 per share.

* Atara Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.